Mitral valve repair in patients with low left ventricular ejection fractions: Early and late results
Cardiac Output, Low
Coronary Artery Bypass
Heart Valve Prosthesis Implantation
Mitral Valve Insufficiency
Ventricular Dysfunction, Left
Good symptomatic relief and acceptable overall survival can be obtained in patients in both groups after they have undergone MVP, in the absence of serious comorbidities. Preoperative NYHA class IV and end-stage IHD increase early and late mortality, particularly in group II patients, in whom surgery may be a salvage effort only. Prognosis is dismal in group II patients who have previously undergone CABG. In chronic cases, an early referral for MVP electively before deterioration to end-stage heart disease would improve survival even in patients with low LVEF.